IGO (ASX:IGO) - Former CEO & Managing Director, Peter Bradford
Former CEO & Managing Director, Peter Bradford
Source: Peter Bradford/LinkedIn
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • IGO (ASX:IGO) announces it expects to record a non-cash, pre-tax impairment expense after processing the purchase of Western Areas (WSA) in June last year
  • impairment is expected between $880m and $980m in its financial results for FY23
  • It is in relation to the reassessment of the accounting value at Cosmos and Forrestania reflecting higher capital and operating costs, challenges to the mine production schedule, and delays in development
  • The non-cash impairment will not impact the FY23 EBITDA, it will be recorded in the Company’s FY23 Audited Financial Result
  • The project’s review to better understand the risks is expected in the December quarter, with June quarterly results scheduled for the end of July
  • Shares were down 4.87 per cent at $15.33 at 12:12 pm AEST

IGO (IGO) has announced it expects to record a non-cash, pre-tax impairment expense after processing the purchase price allocation of Western Areas (WSA) in June last year.

The company expects an impairment of between $880 million and A$980 million in its financial results for the 2023 financial year.

The impairment is in relation to the reassessment of the accounting value at Cosmos and Forrestania reflecting higher capital and operating costs, challenges to the mine production schedule and delays in development.

As a result, guidance provided on the 31st of October 2022 in relation to Cosmos has been withdrawn.

While the non-cash impairment will not impact the FY23 EBITDA, it will be recorded in the Company’s FY23 Audited Financial Result.

The impairment does not include changes in the mark-to-market value of IGO’s shareholding in Panoramic Resources, which is acquired as part of the WSA acquisition.

IGO’s acting CEO, Matt Dusci said he is “disappointed” by the “significant impairment.

“While the project development team has made solid progress to advance Cosmos towards first production, capital and operating cost escalation and unforeseen operational challenges have impacted the value of the Project,” Mr Dusci said.

“As a long-life nickel asset, Cosmos remains important to our nickel business and provides potential downstream optionality via our aspirations to develop an Integrated Battery Materials Facility in Western Australia.”

The review of the project to better understand the risks is expected in the December quarter, with June quarterly results scheduled to be released at the end of July.

IGO was down 4.87 per cent at $15.33 at 12:12 pm AEST.

IGO by the numbers
More From The Market Online
A patient being dosed with Imugene Limited testing materials.

First Aussie doses bring Imugene major step closer to ‘quicker, cheaper’ non-Hodgkin’s lymphoma care

Imugene Limited (ASX:IMU) has hit its first important milestone in 2025, dosing its first Australian patient with its allogenic
A market trading board with ASX marked on the side.

‘Shine a light’: ASX to get more aggressive on companies ‘not up to scratch’ on disclosures

The Australian Securities Exchange (ASX:ASX) will be taking poor disclosure from market-listed companies far more seriously through this next
The words "Market Open" appear stacked atop one another next to ASX company iconography.

ASX Market Open: Ever-extending US loss streak to bleed into red Friday – unless Oz bucks trend again | Jan 3, 2024

The ASX 200 is expected to open 0.07% lower at 8,185 points, though after
Market Close Graphic

ASX Market Close: Bourse defies red futures to end up on 2025’s first trading day | Jan 2, 2024

The local bourse has defied morning predictions to end 34 points up, at 8,189 (a 0.44% gain) after ASX 200 futures originally suggested...